Ray KK - Search Results

1

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.

Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Dwyer JP, Corbalan R, Hamm C, Kaplan L, Nicolau JC, Ophuis TO, Ray KK, Ruda M, Spinar J, Patel T, Miao W, Perdomo C, Francis B, Dhadda S, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD; CAMELLIA-TIMI 61 Steering Committee Investigators. Bohula EA, et al. Among authors: ray kk. Lancet. 2018 Nov 24;392(10161):2269-2279. doi: 10.1016/S0140-6736(18)32328-6. Epub 2018 Oct 4. Lancet. 2018. PMID: 30293771 Free article. Clinical Trial.

2

Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.

Ray KK, Morrow DA, Gibson CM, Murphy S, Antman EM, Braunwald E. Ray KK, et al. Eur Heart J. 2005 Mar;26(5):440-6. doi: 10.1093/eurheartj/ehi104. Epub 2005 Jan 26. Eur Heart J. 2005. PMID: 15673542 Clinical Trial.

3

C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial).

Moghbeli N, Kirtane AJ, Ray KK, Murphy SA, Gibson CM, Braunwald E, Cannon CP; TIMI Study Group. Moghbeli N, et al. Among authors: ray kk. Am J Cardiol. 2005 Sep 1;96(5):635-8. doi: 10.1016/j.amjcard.2005.04.033. Am J Cardiol. 2005. PMID: 16125484

4

Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.

Wiviott SD, Cannon CP, Morrow DA, Ray KK, Pfeffer MA, Braunwald E; PROVE IT-TIMI 22 Investigators. Wiviott SD, et al. Among authors: ray kk. J Am Coll Cardiol. 2005 Oct 18;46(8):1411-6. doi: 10.1016/j.jacc.2005.04.064. J Am Coll Cardiol. 2005. PMID: 16226163 Free article.

5

Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.

Scirica BM, Morrow DA, Cannon CP, Ray KK, Sabatine MS, Jarolim P, Shui A, McCabe CH, Braunwald E; PROVE IT-TIMI 22 Investigators. Scirica BM, et al. Among authors: ray kk. J Am Coll Cardiol. 2006 Jun 6;47(11):2326-31. doi: 10.1016/j.jacc.2006.03.034. Epub 2006 May 4. J Am Coll Cardiol. 2006. PMID: 16750703 Free article.

6

Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS.

Ray KK, Bach RG, Cannon CP, Cairns R, Kirtane AJ, Wiviott SD, McCabe CH, Braunwald E, Gibson CM; PROVE IT-TIMI 22 Investigators. Ray KK, et al. Eur Heart J. 2006 Oct;27(19):2310-6. doi: 10.1093/eurheartj/ehl180. Epub 2006 Aug 3. Eur Heart J. 2006. PMID: 16887854 Clinical Trial.

7

Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.

Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, Braunwald E. Ray KK, et al. Circulation. 2007 Jun 19;115(24):3071-8. doi: 10.1161/CIRCULATIONAHA.106.666511. Epub 2007 Jun 4. Circulation. 2007. PMID: 17548728 Clinical Trial.

8

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.

Miller M, Cannon CP, Murphy SA, Qin J, Ray KK, Braunwald E; PROVE IT-TIMI 22 Investigators. Miller M, et al. Among authors: ray kk. J Am Coll Cardiol. 2008 Feb 19;51(7):724-30. doi: 10.1016/j.jacc.2007.10.038. J Am Coll Cardiol. 2008. PMID: 18279736 Free article. Clinical Trial.

9

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.

Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. Ray KK, et al. Lancet. 2009 May 23;373(9677):1765-72. doi: 10.1016/S0140-6736(09)60697-8. Lancet. 2009. PMID: 19465231

10

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I. Sattar N, et al. Among authors: ray kk. Lancet. 2010 Feb 27;375(9716):735-42. doi: 10.1016/S0140-6736(09)61965-6. Epub 2010 Feb 16. Lancet. 2010. PMID: 20167359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

393 results

Search Page